SPID ®-Technology utilizes compartmentalization to enable sequential release of carbidopa and levodopa, offering a potential new approach for drug delivery in Parkinson’s disease treatment. "Levodopa ...
The Plausible Mechanism Pathway allows FDA drug approval without randomized trials, focusing on diseases with known biological causes. This pathway targets rare genetic diseases, emphasizing biologic ...
In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.
The addition of levodopa doesn’t improve motor function among patients receiving inpatient rehabilitation therapy after an acute stroke, according to the results of the placebo-controlled ESTREL trial ...
DEAR DR. ROACH: I’m a 65-year-old and otherwise healthy male. After spending the past five years believing that my trembling hands were the result of essential tremor, a second DaT (dopamine ...
I’ve been going down a gaming handheld rabbit hole for the last few years, spurred on by the Steam Deck back in 2022. While these PC handhelds definitely existed before that – usually with laptop ...
A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better ...
Researchers in Australia have created a biodegradable gel that delivers Parkinson’s medications through a single weekly shot, replacing the need for multiple daily pills. Injected just under the skin, ...
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the ...
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the ...
- Analysis of RISE-PD presented at AAN 2025 showed CREXONT treatment significantly improved patients’ Parkinson’s Disease Sleep Scale-2 (PDSS-2) total and sub-scale scores - Treatment with CREXONT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results